PharmaJet Receives Grand Challenges Explorations Funding
PharmaJet Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to pursue innovations that address persistent health and development challenges. Dr. Linda... - November 16, 2011
PharmaJet FDA Regulatory Clearances on Its Needle-Free Injection Devices
PharmaJet has received two FDA 510(k) marketing clearances for its IM/SC injection technology. Below are the Indications For Use, cleared by the FDA. FDA 510(k) Number K111517: PharmaJet Stratis Needle-free Injection System: The PharmaJet Stratis Needle-free Injection System is intended to... - October 25, 2011
Kroger Launches Flu Shot Campaign with PharmaJet Needle-free Injection Devices
Kroger will offer the PharmaJet needle-free injection option at over 800 Kroger and The Little Clinics locations nationwide. - September 23, 2011
PharmaJet's Heather Callender-Potters Named Ernst & Young Entrepreneur of the Year 2011 Mountain Desert Region Award Finalist
Selected by a panel of independent judges, the Entrepreneur of the Year award finalists are chosen based on their extraordinary success, vision and personal commitment to their business and community. - May 25, 2011
FDA Grants PharmaJet 510(k) Clearance on Intradermal Needle-free Injection Device
First FDA-cleared needle-free injection alternative to needle-based “Mantoux” method. - March 25, 2011
CDC Awards Contract to PharmaJet for Development of Needle‐free Intradermal Vaccine Delivery Device
Funding advances development of needle‐free injector that enables reduced doses and antigen‐sparing of vaccines. - February 03, 2011
PharmaJet and USAMRIID Enter Collaboration on Continued Development of Future-Generation Smallpox Vaccine Combined with Needle-Free Delivery Technology
Searching for for effective methods to deliver DNA vaccines, USAMRIID's experimental vaccine against smallpox will be evaluated in pre-clinical studies utilizing PharmaJet's needle-free injection technology - December 08, 2010
Inviragen and Pharmajet Receive $15.5 Million NIAID Contract to Develop a Needle-Free Dengue Vaccine
This joint contract with PharmaJet and Inviragen will one day aid in the 30-50 million cases of debilitating dengue fever and 0.5 - 2 million cases of life-threatening dengue hemorrhagic fever every year. - October 13, 2010
Co-Founders of PharmaJet Honored as Laureate of The Tech Museum’s Tech Awards in 2010
(Laureate) is One of 15 Innovators From Around the World Recognized for Applying Technology to Benefit Humanity - October 04, 2010